HENDERSON MICHAEL THOMAS

CIK 00017799904 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001779990

Recent Transactions

50 trades

Gift
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-07-10−75,046→ 920,941 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-07-08$133.63/sh−20,000→ 995,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-22$132.54/sh−80,000→ 1,015,987 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-06-22$100.00/sh−20,000→ 68,606 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-10$86.27/sh−2,305→ 1,096,601 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-10$82.21/sh−6,770→ 1,109,217 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-10$84.18/sh−1,080→ 1,100,483 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-10$82.78/sh−7,654→ 1,101,563 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-10$85.19/sh−1,577→ 1,098,906 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-06-10$86.89/sh−614→ 1,095,987 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2026-05-27+8,026→ 8,026 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-05-13$82.58/sh−1,341→ 1,115,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-05-13$82.05/sh−18,659→ 1,117,328 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-05-08$74.76/sh−24,814→ 107,875 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-05-08$73.72/sh−33,513→ 132,689 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-05-08$72.57/sh−2,404→ 166,202 total
Sale
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-05-08$75.35/sh−19,269→ 88,606 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-04-16−3,000→ 387,012 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-04-16$22.86/sh+3,000→ 1,135,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-04-08$83.26/sh−2,000→ 1,133,187 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-04-08$85.00/sh−200→ 1,132,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-04-08$82.48/sh−17,800→ 1,135,187 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-11$74.29/sh−8,363→ 1,164,624 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-11$74.83/sh−8,219→ 1,156,405 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-03-11$75.86/sh−3,418→ 1,152,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-11$63.73/sh−7,551→ 1,173,942 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-11$64.99/sh−955→ 1,172,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-02-11$62.96/sh−11,494→ 1,181,493 total
Other
Spyre Therapeutics, Inc.$SYRE
Common Stock
2026-01-21+63,227→ 168,606 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$78.64/sh−1,440→ 1,211,547 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$79.82/sh−8,476→ 1,203,071 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$81.00/sh−2,374→ 1,200,697 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$82.41/sh−1,854→ 1,198,843 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$83.16/sh−5,386→ 1,193,457 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2026-01-14$83.79/sh−470→ 1,192,987 total
Award
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2026-01-02+253,016→ 253,016 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-10$74.88/sh−9,435→ 1,223,552 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-10$75.79/sh−10,005→ 1,213,547 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-10$76.58/sh−560→ 1,212,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-12-04$75.01/sh−40,000→ 1,232,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-13$61.93/sh−3,340→ 1,289,647 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-13$63.89/sh−1,786→ 1,273,087 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-13$63.14/sh−14,774→ 1,274,873 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-11-13$64.52/sh−100→ 1,272,987 total
Award
Spyre Therapeutics, Inc.$SYRE
Stock Option (Right to Buy)
2025-05-29+25,000→ 25,000 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-03-05$29.98/sh−7,326→ 1,295,661 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-03-05$30.62/sh−2,674→ 1,292,987 total
Sale
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-02-05$40.58/sh−15,000→ 1,302,987 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Common Stock
2025-01-31$22.86/sh+8,500→ 1,317,987 total
Exercise/Conversion
Apogee Therapeutics, Inc.$APGE
Stock Option (Right to Buy)
2025-01-31−8,500→ 390,012 total

Companies

Recent Filings

Address

C/O APOGEE THERAPEUTICS, INC. 1 LETTERMAN DRIVE, BUILDING B

SAN FRANCISCO, CA, 94129

View on SEC.gov